Geron Profit Margin

The latest profit margin for GERN is -35.48% as of March 2026. That compares with -119.6% in the prior-year period — up 70.3% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Geron's historical trend and sector peers before judging valuation or financial health.

Over the past year, GERN's profit margin moved from -119.6% to -35.48% — a 70.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Geron's valuation or profitability profile.

Against Healthcare companies, GERN currently prints -35.48% for profit margin, while the sector average sits near 15.29%. That is roughly 332.0% below the sector mean. Large gaps often invite a closer look at Geron's growth, margins, and balance sheet.

Profit Margin shows how effectively Geron converts resources into returns. At -35.48%, GERN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -119.6% in the prior-year period — up 70.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting GERN's profit margin (-35.48%), review year-over-year change from -119.6%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.